These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


947 related items for PubMed ID: 30521551

  • 1. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
    Vernocchi P, Del Chierico F, Russo A, Majo F, Rossitto M, Valerio M, Casadei L, La Storia A, De Filippis F, Rizzo C, Manetti C, Paci P, Ercolini D, Marini F, Fiscarelli EV, Dallapiccola B, Lucidi V, Miccheli A, Putignani L.
    PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gut microbiota in adults with cystic fibrosis: Implications for the severity of the CFTR gene mutation and nutritional status.
    Durda-Masny M, Goździk-Spychalska J, Morańska K, Pawłowska N, Mazurkiewicz M, Skrzypczak I, Cofta S, Szwed A.
    J Cyst Fibros; 2024 Sep; 23(5):977-983. PubMed ID: 38960841
    [Abstract] [Full Text] [Related]

  • 6. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
    Bertolini A, Nguyen M, Zehra SA, Taleb SA, Bauer-Pisani T, Palm N, Strazzabosco M, Fiorotto R.
    J Hepatol; 2024 Sep; 81(3):429-440. PubMed ID: 38554847
    [Abstract] [Full Text] [Related]

  • 7. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.
    Vernocchi P, Del Chierico F, Quagliariello A, Ercolini D, Lucidi V, Putignani L.
    Nutrients; 2017 Dec 09; 9(12):. PubMed ID: 29232848
    [Abstract] [Full Text] [Related]

  • 8. The Microbiome in Cystic Fibrosis Pulmonary Disease.
    Françoise A, Héry-Arnaud G.
    Genes (Basel); 2020 May 11; 11(5):. PubMed ID: 32403302
    [Abstract] [Full Text] [Related]

  • 9. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
    Young SM, Woode RA, Williams EC, Ericsson AC, Clarke LL.
    Physiol Genomics; 2024 Mar 01; 56(3):247-264. PubMed ID: 38073491
    [Abstract] [Full Text] [Related]

  • 10. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
    Ooi CY, Syed SA, Rossi L, Garg M, Needham B, Avolio J, Young K, Surette MG, Gonska T.
    Sci Rep; 2018 Dec 13; 8(1):17834. PubMed ID: 30546102
    [Abstract] [Full Text] [Related]

  • 11. CFTR dysregulation drives active selection of the gut microbiome.
    Meeker SM, Mears KS, Sangwan N, Brittnacher MJ, Weiss EJ, Treuting PM, Tolley N, Pope CE, Hager KR, Vo AT, Paik J, Frevert CW, Hayden HS, Hoffman LR, Miller SI, Hajjar AM.
    PLoS Pathog; 2020 Jan 13; 16(1):e1008251. PubMed ID: 31961914
    [Abstract] [Full Text] [Related]

  • 12. An in vitro medium for modeling gut dysbiosis associated with cystic fibrosis.
    Barrack KE, Hampton TH, Valls RA, Surve SV, Gardner TB, Sanville JL, Madan JL, O'Toole GA.
    J Bacteriol; 2024 Jan 25; 206(1):e0028623. PubMed ID: 38169295
    [Abstract] [Full Text] [Related]

  • 13. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
    Caley LR, White H, de Goffau MC, Floto RA, Parkhill J, Marsland B, Peckham DG.
    Dig Dis Sci; 2023 May 25; 68(5):1797-1814. PubMed ID: 36600119
    [Abstract] [Full Text] [Related]

  • 14. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
    Madan JC.
    Clin Ther; 2016 Apr 25; 38(4):740-6. PubMed ID: 26973296
    [Abstract] [Full Text] [Related]

  • 15. Lung and Gut Microbiota Changes Associated with Pseudomonas aeruginosa Infection in Mouse Models of Cystic Fibrosis.
    Bacci G, Rossi A, Armanini F, Cangioli L, De Fino I, Segata N, Mengoni A, Bragonzi A, Bevivino A.
    Int J Mol Sci; 2021 Nov 10; 22(22):. PubMed ID: 34830048
    [Abstract] [Full Text] [Related]

  • 16. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis.
    Li L, Krause L, Somerset S.
    Clin Nutr; 2017 Aug 10; 36(4):1097-1104. PubMed ID: 27595636
    [Abstract] [Full Text] [Related]

  • 17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr 10; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 18. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.
    Nielsen S, Needham B, Leach ST, Day AS, Jaffe A, Thomas T, Ooi CY.
    Sci Rep; 2016 May 04; 6():24857. PubMed ID: 27143104
    [Abstract] [Full Text] [Related]

  • 19. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y, Zhang X, Yang R, Jiang R, Xu Y, Qin H.
    Physiol Genomics; 2018 Oct 01; 50(10):893-903. PubMed ID: 30192713
    [Abstract] [Full Text] [Related]

  • 20. The gut-lung axis in the CFTR modulator era.
    Lussac-Sorton F, Charpentier É, Imbert S, Lefranc M, Bui S, Fayon M, Berger P, Enaud R, Delhaes L.
    Front Cell Infect Microbiol; 2023 Oct 01; 13():1271117. PubMed ID: 37780857
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.